COVID-19 (death) |
Comorbidities |
Neurological disorder [Present vs. Not present] |
Hazard ratio: 1.170 (1.060-1.290)
§ |
Docherty
|
|
|
COVID-19 (death) |
Comorbidities |
Obesity [Present vs. Not present] |
Hazard ratio: 1.330 (1.190-1.490)
§ |
Docherty
|
|
|
COVID-19 (death) |
Comorbidities |
Diabetes [Present vs. Not present] |
Hazard ratio: 1.060 (0.990-1.140)
§ |
Docherty
|
|
|
COVID-19 (death) |
Comorbidities |
Chronic kidney disease [Present vs. Not present] |
Hazard ratio: 1.280 (1.180-1.390)
§ |
Docherty
|
|
|
COVID-19 (death) |
Comorbidities |
Chronic respiratory disease [Present vs. Not present] |
Hazard ratio: 1.170 (1.090-1.270)
§ |
Docherty
|
|
|
COVID-19 (death) |
Comorbidities |
Chronic cardiac disease [Present vs. Not present] |
Hazard ratio: 1.160 (1.080-1.240)
§ |
Docherty
|
|
|
COVID-19 (death) |
Patient characteristics |
Gender [Female vs. Male] |
Hazard ratio: 0.810 (0.750-0.860)
§ |
Docherty
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [>=80 vs. <50 years] |
Hazard ratio: 11.090 (8.930-13.770)
§ |
Docherty
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [70-79 years vs. <50 years] |
Hazard ratio: 8.510 (6.850-10.570)
§ |
Docherty
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [60-69 years vs. <50 years] |
Hazard ratio: 4.990 (3.990-6.250)
§ |
Docherty
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [50-59 years vs. <50 years] |
Hazard ratio: 2.630 (2.060-3.350)
§ |
Docherty
|
|
|
SARS COV-2 infection |
Symptoms |
Ageusia [Present vs. Not present] |
Odds ratio: 4.760 (1.500-14.800)
§ |
Corbellini
|
|
|
SARS COV-2 infection |
Symptoms |
Anosmia [Present vs. Not present] |
Odds ratio: 18.470 (2.310-147.700)
§ |
Corbellini
|
|
|
SARS COV-2 infection |
Symptoms |
Smell or taste change [Present vs. Not present] |
Odds ratio: 21.400 (2.770-165.400)
§ |
Corbellini
|
|
|
COVID-19 (death) |
Treatment |
Treatment for COVID-19 [Treated with tocilizumab vs. Not received] |
Hazard ratio: 0.035 (0.004-0.347)
§ |
Capra
|
|
|
COVID-19 in diabetes (severe/fatal) |
Laboratory Findings |
Glucose [1 unit increase vs. Not applicable] |
Odds ratio: 1.060 (0.960-1.170)
§ |
Chen
|
|
|
COVID-19 in diabetes (severe/fatal) |
Laboratory Findings |
CRP [1 unit increase vs. Not applicable] |
Odds ratio: 1.160 (1.010-1.320)
§ |
Chen
|
|
|
COVID-19 in diabetes (severe/fatal) |
Laboratory Findings |
Creatinine [1 unit increase vs. Not applicable] |
Odds ratio: 1.010 (1.000-1.020)
§ |
Chen
|
|
|
COVID-19 in diabetes (severe/fatal) |
Laboratory Findings |
Albumin [1 unit increase vs. Not applicable] |
Odds ratio: 0.910 (0.830-0.990)
§ |
Chen
|
|
|
COVID-19 in diabetes (death) |
Laboratory Findings |
Glucose [1 unit increase vs. Not applicable] |
Odds ratio: 1.070 (0.970-1.170)
§ |
Chen
|
|
|
COVID-19 in diabetes (death) |
Laboratory Findings |
CRP [1 unit increase vs. Not applicable] |
Odds ratio: 1.120 (1.000-1.240)
§ |
Chen
|
|
|
COVID-19 in diabetes (death) |
Laboratory Findings |
Creatinine [1 unit increase vs. Not applicable] |
Odds ratio: 1.001 (1.001-1.002)
§ |
Chen
|
|
|
COVID-19 in diabetes (death) |
Laboratory Findings |
Albumin [1 unit increase vs. Not applicable] |
Odds ratio: 0.940 (0.840-1.050)
§ |
Chen
|
|
|
COVID-19 (severe/fatal) |
Laboratory Findings |
Glucose [1 unit increase vs. Not applicable] |
Odds ratio: 1.060 (1.000-1.130)
§ |
Chen
|
|
|
COVID-19 (severe/fatal) |
Laboratory Findings |
CRP [1 unit increase vs. Not applicable] |
Odds ratio: 1.200 (1.130-1.280)
§ |
Chen
|
|
|
COVID-19 (severe/fatal) |
Laboratory Findings |
Creatinine [1 unit increase vs. Not applicable] |
Odds ratio: 1.000 (1.000-1.010)
§ |
Chen
|
|
|
COVID-19 (severe/fatal) |
Laboratory Findings |
Albumin [1 unit increase vs. Not applicable] |
Odds ratio: 0.980 (0.950-1.020)
§ |
Chen
|
|
|
COVID-19 (death) |
Laboratory Findings |
Glucose [1 unit increase vs. Not applicable] |
Odds ratio: 1.080 (1.010-1.160)
§ |
Chen
|
|
|
COVID-19 (death) |
Laboratory Findings |
CRP [1 unit increase vs. Not applicable] |
Odds ratio: 1.140 (1.080-1.210)
§ |
Chen
|
|
|
COVID-19 (death) |
Laboratory Findings |
Creatinine [1 unit increase vs. Not applicable] |
Odds ratio: 1.000 (1.000-1.000)
§ |
Chen
|
|
|
COVID-19 (death) |
Laboratory Findings |
Albumin [1 unit increase vs. Not applicable] |
Odds ratio: 0.910 (0.860-0.970)
§ |
Chen
|
|
|
COVID-19 in diabetes (severe/fatal) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.020 (0.990-1.050)
§ |
Chen
|
|
|
COVID-19 in diabetes (death) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.090 (1.040-1.150)
§ |
Chen
|
|
|
COVID-19 (severe/fatal) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.020 (1.010-1.030)
§ |
Chen
|
|
|
COVID-19 (death) |
Patient characteristics |
Age [1 year increase vs. Not applicable] |
Odds ratio: 1.090 (1.070-1.120)
§ |
Chen
|
|
|
SARS COV-2 infection |
Symptoms |
Sore throat [Present vs. Not present] |
Odds ratio: 0.667 (0.622-0.715)
§ |
Menni
|
|
|
SARS COV-2 infection |
Symptoms |
Chest pain [Present vs. Not present] |
Odds ratio: 1.170 (1.096-1.249)
§ |
Menni
|
|
|
SARS COV-2 infection |
Symptoms |
Abdominal pain [Present vs. Not present] |
Odds ratio: 1.231 (1.136-1.335)
§ |
Menni
|
|
|
SARS COV-2 infection |
Symptoms |
Shortness of breath [Present vs. Not present] |
Odds ratio: 1.261 (1.219-1.306)
§ |
Menni
|
|
|
SARS COV-2 infection |
Symptoms |
Headache [Present vs. Not present] |
Odds ratio: 1.336 (1.243-1.436)
§ |
Menni
|
|
|
SARS COV-2 infection |
Symptoms |
Hoarse voice [Present vs. Not present] |
Odds ratio: 1.353 (1.261-1.452)
§ |
Menni
|
|
|
SARS COV-2 infection |
Symptoms |
Delirium [Present vs. Not present] |
Odds ratio: 1.404 (1.286-1.534)
§ |
Menni
|
|
|
SARS COV-2 infection |
Symptoms |
Diarrhoea [Present vs. Not present] |
Odds ratio: 1.479 (1.370-1.596)
§ |
Menni
|
|
|
SARS COV-2 infection |
Symptoms |
Persistent cough [Present vs. Not present] |
Odds ratio: 1.571 (1.473-1.675)
§ |
Menni
|
|
|
SARS COV-2 infection |
Symptoms |
Fever [Present vs. Not present] |
Odds ratio: 1.653 (1.539-1.775)
§ |
Menni
|
|
|
SARS COV-2 infection |
Symptoms |
Fatigue [Present vs. Not present] |
Odds ratio: 2.016 (1.920-2.116)
§ |
Menni
|
|
|
SARS COV-2 infection |
Symptoms |
Skipped meals [Present vs. Not present] |
Odds ratio: 2.239 (2.090-2.399)
§ |
Menni
|
|
|
SARS COV-2 infection |
Symptoms |
Anosmia [Present vs. Not present] |
Odds ratio: 6.397 (5.958-6.870)
§ |
Menni
|
|
|
COVID-19 (severe/fatal) |
Patient characteristics |
BMI for Women [Obesity (>=28 kg/m2) vs. Normal (18.5–23.9 kg/m2)] |
Odds ratio: 0.700 (0.070-7.200)
§ |
Cai
|
|
|
COVID-19 (severe/fatal) |
Patient characteristics |
BMI for Women [Overweight (24–27.9 kg/m2) vs. Normal (18.5–23.9 kg/m2)] |
Odds ratio: 1.640 (0.630-4.290)
§ |
Cai
|
|
|